However, this reduction did not reach statistical significance due to the very low proportion ( n / N = 7/261) of participants in this group.
← all excerpts
Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study.
1
—
—